BioSpace News Archive

Recognition marks fourth consecutive year as top-ranked Phase I provider to work with; Company ranked among top-two global CROs for Service Provider Leadership, Familiarity, Use and Preference in Phase I

Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company will be presenting at the Oppenheimer Rare & Orphan Disease Summit on Friday, May 21, 2021 and will be hosting virtual one-on-one meetings with investors throughout the day.

Genetic Technologies Limited, a diversified Genomics and AI driven preventative health business, announced an interview with Simon Morriss, CEO, will air on The RedChip Money Report® on the Bloomberg Network in the U.S. on Saturday, May 15th, at 7 p.m. local time in 73M homes across the United States.

Mobilogix, the leading provider of cost-optimized State of the Art cellular IoT solutions, is pleased to announce a strategic partnership with Comprovei, a leading Logistics and Delivery Management Solution Provider.

California Surgeon General Leads the Effort with NumberStory.org, the First One-Stop Shop for Consumers to Learn more About ACEs

Medtronic plc and the Medtronic Foundation announced an additional $3M USD for COVID-19 relief efforts – a combination of financial resources, personal protective equipment donations, and Medtronic employee engagement – focused on underserved areas of India, Brazil, the United States, and other global regions.

Intuition Robotics, developer of digital companion™ technologies, announced today that Dr. Michael Cantor, MD. has been named the first Chief Medical Officer of the company.

In Southern California, insured patients had higher rates of survival when diagnosed at Kaiser Permanente hospitals than when diagnosed elsewhere

Healionics Corporation, a private medical device company, announced today the completion of a $4.7M equity financing round led by Keiretsu Capital. The company also announced the conversion to equity of $5.2M in previously outstanding notes and interest.

Devonian Health Group Inc., a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products is pleased to announce that Dr. André Boulet, President and CEO, will present at the Canada India Healthcare Summit Conference being held virtually from May 20-21, 2021.